tiprankstipranks
Trending News
More News >
CVS Health Corp (GB:0HRS)
:0HRS
UK Market

CVS Health (0HRS) Share Forecast & Price Target

Compare
4 Followers
See the Price Targets and Ratings of:

0HRS Analyst Ratings

Strong Buy
17Ratings
Strong Buy
15 Buy
2 Hold
0 Sell
Based on 17 analysts giving stock ratings to
CVS
Health
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

0HRS Stock 12 Month Forecast

Average Price Target

$80.13
▲( 32.27% Upside)
Based on 17 Wall Street analysts offering 12 month price targets for CVS Health in the last 3 months. The average price target is $80.13 with a high forecast of $95.00 and a low forecast of $71.00. The average price target represents a 32.27% change from the last price of $60.58.
{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"42":"$42","69":"$69","96":"$96","55.5":"$55.5","82.5":"$82.5"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":95,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$95.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":80.13,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$80.13</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":71,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$71.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[42,55.5,69,82.5,96],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Aug<br/>2024","6":"Nov<br/>2024","9":"Feb<br/>2025","12":"May<br/>2025","25":"May<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,70.863,72.71969230769231,74.57638461538461,76.43307692307692,78.28976923076922,80.14646153846154,82.00315384615385,83.85984615384615,85.71653846153846,87.57323076923078,89.42992307692307,91.28661538461539,93.14330769230769,{"y":95,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,70.863,71.57584615384616,72.2886923076923,73.00153846153846,73.71438461538462,74.42723076923076,75.14007692307692,75.85292307692308,76.56576923076923,77.27861538461538,77.99146153846154,78.7043076923077,79.41715384615384,{"y":80.13,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,70.863,70.87353846153846,70.88407692307692,70.89461538461538,70.90515384615385,70.91569230769231,70.92623076923077,70.93676923076923,70.94730769230769,70.95784615384615,70.96838461538462,70.97892307692308,70.98946153846154,{"y":71,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":53.298,"date":1714521600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 20,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 17, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":56.007,"date":1717200000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 20,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 19, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":55.958,"date":1719792000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 15,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 22, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":58.038,"date":1722470400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 19, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":55.195,"date":1725148800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 16, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":59.031,"date":1727740800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 25,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 15, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":54.961,"date":1730419200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 35,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 11, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":57.729,"date":1733011200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 41,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 12, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":43.331,"date":1735689600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 34,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 11, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":56.3,"date":1738368000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 35,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":63.861,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 34,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":66.989,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 35,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":70.863,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 31,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
Highest Price Target$95.00Average Price Target$80.13Lowest Price Target$71.00
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Leerink Partners Analyst forecast on GB:0HRS
Michael ChernyLeerink Partners
Leerink Partners
$83
Buy
37.01%
Upside
Reiterated
05/19/25
Truist Financial Analyst forecast on GB:0HRS
David S MacdonaldTruist Financial
Truist Financial
$82$84
Buy
38.66%
Upside
Reiterated
05/12/25
J.P. Morgan Analyst forecast on GB:0HRS
Lisa GillJ.P. Morgan
J.P. Morgan
$81$86
Buy
41.96%
Upside
Reiterated
05/07/25
Evercore ISI
$85
Buy
40.31%
Upside
Reiterated
05/07/25
Accountability Research Analyst forecast on GB:0HRS
Unknown AnalystAccountability Research
Not Ranked
Accountability Research
$74
Buy
22.15%
Upside
Upgraded
05/06/25
Cantor Fitzgerald Analyst forecast on GB:0HRS
Sarah JamesCantor Fitzgerald
Cantor Fitzgerald
$71
Buy
17.20%
Upside
Reiterated
05/05/25
Argus Research Analyst forecast on GB:0HRS
Steven SilverArgus Research
Argus Research
Buy
Reiterated
05/05/25
TD Cowen
$90$95
Buy
56.82%
Upside
Reiterated
05/05/25
Wells Fargo Analyst forecast on GB:0HRS
Stephen BaxterWells Fargo
Wells Fargo
$76$84
Buy
38.66%
Upside
Reiterated
05/05/25
RBC Capital Analyst forecast on GB:0HRS
Ben HendrixRBC Capital
RBC Capital
$74$81
Buy
33.71%
Upside
Reiterated
05/04/25
Bank of America Securities Analyst forecast on GB:0HRS
Allen LutzBank of America Securities
Bank of America Securities
$80$85
Buy
40.31%
Upside
Reiterated
05/02/25
UBS
$67$71
Hold
17.20%
Upside
Reiterated
05/02/25
Barclays
$73$82
Buy
35.36%
Upside
Reiterated
05/02/25
Morgan Stanley Analyst forecast on GB:0HRS
Erin WrightMorgan Stanley
Morgan Stanley
$68$80
Buy
32.06%
Upside
Reiterated
04/15/25
Robert W. Baird Analyst forecast on GB:0HRS
Michael HaRobert W. Baird
Robert W. Baird
$51$71
Hold
17.20%
Upside
Reiterated
04/15/25
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Leerink Partners Analyst forecast on GB:0HRS
Michael ChernyLeerink Partners
Leerink Partners
$83
Buy
37.01%
Upside
Reiterated
05/19/25
Truist Financial Analyst forecast on GB:0HRS
David S MacdonaldTruist Financial
Truist Financial
$82$84
Buy
38.66%
Upside
Reiterated
05/12/25
J.P. Morgan Analyst forecast on GB:0HRS
Lisa GillJ.P. Morgan
J.P. Morgan
$81$86
Buy
41.96%
Upside
Reiterated
05/07/25
Evercore ISI
$85
Buy
40.31%
Upside
Reiterated
05/07/25
Accountability Research Analyst forecast on GB:0HRS
Unknown AnalystAccountability Research
Not Ranked
Accountability Research
$74
Buy
22.15%
Upside
Upgraded
05/06/25
Cantor Fitzgerald Analyst forecast on GB:0HRS
Sarah JamesCantor Fitzgerald
Cantor Fitzgerald
$71
Buy
17.20%
Upside
Reiterated
05/05/25
Argus Research Analyst forecast on GB:0HRS
Steven SilverArgus Research
Argus Research
Buy
Reiterated
05/05/25
TD Cowen
$90$95
Buy
56.82%
Upside
Reiterated
05/05/25
Wells Fargo Analyst forecast on GB:0HRS
Stephen BaxterWells Fargo
Wells Fargo
$76$84
Buy
38.66%
Upside
Reiterated
05/05/25
RBC Capital Analyst forecast on GB:0HRS
Ben HendrixRBC Capital
RBC Capital
$74$81
Buy
33.71%
Upside
Reiterated
05/04/25
Bank of America Securities Analyst forecast on GB:0HRS
Allen LutzBank of America Securities
Bank of America Securities
$80$85
Buy
40.31%
Upside
Reiterated
05/02/25
UBS
$67$71
Hold
17.20%
Upside
Reiterated
05/02/25
Barclays
$73$82
Buy
35.36%
Upside
Reiterated
05/02/25
Morgan Stanley Analyst forecast on GB:0HRS
Erin WrightMorgan Stanley
Morgan Stanley
$68$80
Buy
32.06%
Upside
Reiterated
04/15/25
Robert W. Baird Analyst forecast on GB:0HRS
Michael HaRobert W. Baird
Robert W. Baird
$51$71
Hold
17.20%
Upside
Reiterated
04/15/25
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering CVS Health

1 Month
xxx
Success Rate
18/27 ratings generated profit
67%
Average Return
+1.36%
reiterated a xxx
rating 3 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 66.67% of your transactions generating a profit, with an average return of +1.36% per trade.
3 Months
xxx
Success Rate
12/21 ratings generated profit
57%
Average Return
+1.59%
reiterated a xxx
rating 3 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 57.14% of your transactions generating a profit, with an average return of +1.59% per trade.
1 Year
Michael ChernyLeerink Partners
Success Rate
16/32 ratings generated profit
50%
Average Return
+6.23%
reiterated a buy rating 8 days ago
Copying Michael Cherny's trades and holding each position for 1 Year would result in 50.00% of your transactions generating a profit, with an average return of +6.23% per trade.
2 Years
xxx
Success Rate
14/21 ratings generated profit
67%
Average Return
+14.29%
reiterated a xxx
rating 3 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 66.67% of your transactions generating a profit, with an average return of +14.29% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

0HRS Analyst Recommendation Trends

Rating
Jan 25
Feb 25
Mar 25
Apr 25
May 25
Strong Buy
4
4
2
0
0
Buy
30
31
32
35
31
Hold
11
7
4
3
2
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
45
42
38
38
33
In the current month, 0HRS has received 31 Buy Ratings, 2 Hold Ratings, and 0 Sell Ratings. 0HRS average Analyst price target in the past 3 months is 80.13.
Each month's total comprises the sum of three months' worth of ratings.

0HRS Financial Forecast

0HRS Earnings Forecast

Next quarter’s earnings estimate for 0HRS is $1.45 with a range of $1.32 to $1.72. The previous quarter’s EPS was $2.25. 0HRS beat its EPS estimate 75.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 58.23% of the time in the same period. In the last calendar year 0HRS has Outperformed its overall industry.
Next quarter’s earnings estimate for 0HRS is $1.45 with a range of $1.32 to $1.72. The previous quarter’s EPS was $2.25. 0HRS beat its EPS estimate 75.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 58.23% of the time in the same period. In the last calendar year 0HRS has Outperformed its overall industry.

0HRS Sales Forecast

Next quarter’s sales forecast for 0HRS is $94.93B with a range of $90.83B to $98.80B. The previous quarter’s sales results were $94.61B. 0HRS beat its sales estimates 75.00% of the time in past 12 months, while its overall industry beat sales estimates 47.68% of the time in the same period. In the last calendar year 0HRS has Outperformed its overall industry.
Next quarter’s sales forecast for 0HRS is $94.93B with a range of $90.83B to $98.80B. The previous quarter’s sales results were $94.61B. 0HRS beat its sales estimates 75.00% of the time in past 12 months, while its overall industry beat sales estimates 47.68% of the time in the same period. In the last calendar year 0HRS has Outperformed its overall industry.

0HRS Stock Forecast FAQ

What is GB:0HRS’s average 12-month price target, according to analysts?
Based on analyst ratings, CVS Health Corp’s 12-month average price target is 80.13.
    What is GB:0HRS’s upside potential, based on the analysts’ average price target?
    CVS Health Corp has 32.27% upside potential, based on the analysts’ average price target.
      Can I see which stocks the top-ranking analysts are rating?
      Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
        How can I follow the stock ratings of top Wall Street analysts?
        Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Is CVS Health Corp a Buy, Sell or Hold?
          CVS Health Corp has a consensus rating of Strong Buy, which is based on 15 buy ratings, 2 hold ratings and 0 sell ratings.
            What is CVS Health Corp’s share price target?
            The average share price target for CVS Health Corp is 80.13. This is based on 17 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
            The highest analyst share price target is $95.00 ,and the lowest forecast is $71.00. The average share price target represents 32.27% Increase from the current price of $60.58.
              What do analysts say about CVS Health Corp?
              CVS Health Corp’s analyst rating consensus is a Strong Buy. This is based on the ratings of 17 Wall Streets Analysts.
                How can I buy shares of CVS Health Corp?
                To buy shares of GB:0HRS, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.
                  What am I Missing?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis